Medical News

RSS

AB SCIEX launches MasterView Food Testing Workflow for QTRAP mass spectrometry systems

AB SCIEX, a global leader in analytical technologies, today announced the launch of the MasterView™ Food Testing Workflow for QTRAP® mass spectrometry systems at the 5th Annual FERA/JIFSAN Symposium on Emerging Issues in Food, in York, UK.

10 Jun 2014

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today new pre-clinical results with its Development Candidate (DC) for ALN-CC5, a subcutaneously administered investigational RNAi therapeutic targeting complement component C5 in development for the treatment of complement-mediated diseases.

10 Jun 2014

Auxogyn receives clearance from FDA for Eeva System

Auxogyn, Inc. a leader in women's reproductive health, today announced that its first product, the Eeva System, received clearance from the U.S. Food and Drug Administration through its de novo classification process, a regulatory pathway for select novel, low- to moderate-risk medical devices that are first-of-a-kind.

10 Jun 2014

Liquid Grids launches new Software as a Service platform for healthcare industry

Liquid Grids®, a precision marketing platform for the healthcare industry, announces the launch of its new Software as a Service (SaaS) platform specifically designed for the healthcare industry.

10 Jun 2014

$arGEN-X partner with LLS to develop ARGX-110 for patients with refractory WM$

arGEN-X partner with LLS to develop ARGX-110 for patients with refractory WM

arGEN-X, a clinical stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced it has entered into a partnership with The Leukemia & Lymphoma Society (LLS) in which both parties will contribute to the funding of a Phase 2 clinical study of the Company's lead candidate, ARGX-110, in patients with refractory Waldenström's macroglobulinemia (WM).

10 Jun 2014

Celsion signs definitive asset purchase agreement to acquire EGEN

Celsion Corporation (Celsion) (NASDAQ: CLSN), an oncology drug development company, and EGEN, Inc. (EGEN), a privately-held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, today announced the signing of a definitive asset purchase agreement in which Celsion will acquire substantially all of the assets of EGEN, including its Phase Ib DNA-based immunotherapy product candidate EGEN-001 and its therapeutic platform technologies, TheraPlas™ for delivery of DNA and mRNA, TheraSilence™ for delivery of RNA, and RAST™ for Cell Enabled Expression and Secretion of RNA.

10 Jun 2014

New therapeutic interventions could render addiction into manageable disease

Neuroscientists agree that abuse of drugs hijacks circuits in the brain that are crucial for decision-making, but society as a whole tends to stigmatize addicted people for lacking self-control.

10 Jun 2014

New grant for Emergency/Trauma Care Education Partnership helps move program online

New funding in the amount of $1,103,048 from the Texas Higher Education Coordinating Board's Emergency and Trauma Care Education Partnership (ETEP) grants program has been awarded to Elda G. Ramirez, Ph.D., R.N., associate professor of clinical nursing in the Department of Acute and Continuing Care.

10 Jun 2014

Exercise and diet impact on gut microbial diversity

Scientists at the Science Foundation Ireland-funded Alimentary Pharmabiotic Centre (APC) at University College Cork and Teagasc Food Research Centre, Moorepark, have carried out a study in conjunction with the Irish Rugby Football Union that has revealed that exercise and associated dietary changes influence gut microbial diversity.

10 Jun 2014

First Edition: June 10, 2014

Today's headlines include details of an extensive, nationwide audit of the wait times for care at VA hospitals and clinics.

10 Jun 2014

Professor opens new University of Leicester British Heart Foundation CRC on 11 June 2014

The new University of Leicester British Heart Foundation Cardiovascular Research Centre (CRC) will be officially opened on Wednesday 11 June 2014 by Vice-Chancellor Professor Sir Robert Burgess.

10 Jun 2014

New self-assembling nanoparticle arrays can form highly ordered thin film in 1 minute

The days of self-assembling nanoparticles taking hours to form a film over a microscopic-sized wafer are over. Researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley National Laboratory (Berkeley Lab) have devised a technique whereby self-assembling nanoparticle arrays can form a highly ordered thin film over macroscopic distances in one minute.

10 Jun 2014

electroCore's non-invasive vagus nerve stimulation therapy reduces cluster headache attacks

In a multi-center, randomized, trial across Europe, electroCore's non-invasive vagus nerve stimulation (nVNS) therapy was found to meet its primary endpoint of statistical significance in reducing the number of cluster headache attacks when compared with the standard of care.

10 Jun 2014

MRI shows signs of brain injury in moderate and late preterm babies

Babies born 32 to 36 weeks into gestation may have smaller brains and other brain abnormalities that could lead to long-term developmental problems, according to a new study published online in the journal Radiology.

10 Jun 2014

Nelson adds Technical Consulting Services group for MedTech companies

Nelson Laboratories announced today the expansion of its services with the addition of a dedicated Technical Consulting Services group for MedTech companies.

10 Jun 2014

Viewpoints: 'Triage' at the VA; GOP can't 'fix' health law; mental health problems in LA jail

Washington's attention span on the Veterans Affairs scandal seems to be expiring. Though 42 of the VA's 152 major campuses (27%) are still under investigation for falsifying wait-time records, the Senate is converging on a bipartisan deal that claims to solve the problem.

10 Jun 2014

Pulsar Vascular announces FDA approval of PulseRider IDE for intracranial bifurcation aneurysms

Pulsar Vascular, the innovator and developer of the PulseRider, a minimally invasive, aneurysm neck reconstruction device, announced today the United States Food and Drug Administration's approval of an Investigational Device Exemption (IDE) for the PulseRider.

10 Jun 2014

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity and clinical responses of its immunotherapy product, INO-3112, in treating human papillomavirus (HPV)- associated head and neck cancer.

10 Jun 2014

Aetna partners with Fresenius Medical Care to improve lives of people with end stage renal disease

Fresenius Medical Care announced today a collaborative care model designed to improve the quality of care for Aetna's Medicare Advantage members who have end stage renal disease, while lowering health care costs.

10 Jun 2014

Synthetic, Enterome partner to study effects of beta-lactam antibiotics on gastrointestinal microflora

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, and Enterome Bioscience SA, a pioneer in the development of innovative disease management solutions based on a deep understanding of the gut microbiome, today announced that they have entered into an agreement to conduct metagenomic research on the effects of beta-lactam antibiotics on the gastrointestinal microflora (microbiome) of human patients.

10 Jun 2014

Medical News

AB SCIEX launches MasterView Food Testing Workflow for QTRAP mass spectrometry systems

Alnylam announces new pre-clinical results with DC for ALN-CC5 to treat complement-mediated diseases

Auxogyn receives clearance from FDA for Eeva System

Liquid Grids launches new Software as a Service platform for healthcare industry

arGEN-X partner with LLS to develop ARGX-110 for patients with refractory WM

Celsion signs definitive asset purchase agreement to acquire EGEN

New therapeutic interventions could render addiction into manageable disease

New grant for Emergency/Trauma Care Education Partnership helps move program online

Exercise and diet impact on gut microbial diversity

First Edition: June 10, 2014

Professor opens new University of Leicester British Heart Foundation CRC on 11 June 2014

New self-assembling nanoparticle arrays can form highly ordered thin film in 1 minute

electroCore's non-invasive vagus nerve stimulation therapy reduces cluster headache attacks

MRI shows signs of brain injury in moderate and late preterm babies

Nelson adds Technical Consulting Services group for MedTech companies

Viewpoints: 'Triage' at the VA; GOP can't 'fix' health law; mental health problems in LA jail

Pulsar Vascular announces FDA approval of PulseRider IDE for intracranial bifurcation aneurysms

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Aetna partners with Fresenius Medical Care to improve lives of people with end stage renal disease

Synthetic, Enterome partner to study effects of beta-lactam antibiotics on gastrointestinal microflora

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News